Literature DB >> 17662314

Recognition of category-related visual stimuli in Parkinson's disease: before and after pharmacological treatment.

S Righi1, M P Viggiano, M Paganini, S Ramat, P Marini.   

Abstract

Visual-sensory dysfunctions and semantic processing impairments are widely reported in Parkinson's disease (PD) research. The present study investigated the category-specific deficit in object recognition as a function of both the semantic category and spatial frequency content of stimuli. In the first experiment, the role of dopamine in object-recognition processing was assessed by comparing PD drug naïve (PD-DN), PD receiving levodopa treatment (PD-LD), and control subjects. Experiment 2 consisted of a retest session for PD drug naïve subjects after a period of pharmacological treatment. All participants completed an identification task which displayed animals and tools at nine levels of filtering. Each object was revealed in a sequence of frames whereby the object was presented at increasingly less-filtered images up to a complete version of the image. Results indicate an impaired identification pattern for PD-DN subjects solely for animal category stimuli. This differential pharmacological therapy effect was also confirmed at retest (experiment 2). Thus, our data suggest that dopaminergic loss has a specific role in category-specific impairment. Two possible hypotheses are discussed that may account for the defective recognition of semantically different objects in PD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17662314     DOI: 10.1016/j.neuropsychologia.2007.06.002

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  4 in total

1.  Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: implications for cognitive function.

Authors:  Penny A Macdonald; Oury Monchi
Journal:  Parkinsons Dis       Date:  2011-03-06

2.  The influence of dopamine on automatic and controlled semantic activation in Parkinson's disease.

Authors:  Wendy L Arnott; David A Copland; Helen J Chenery; Bruce E Murdoch; Peter A Silburn; Anthony J Angwin
Journal:  Parkinsons Dis       Date:  2011-11-02

3.  Dopaminergic Therapy Increases Go Timeouts in the Go/No-Go Task in Patients with Parkinson's Disease.

Authors:  Xue Q Yang; Brian Lauzon; Ken N Seergobin; Penny A MacDonald
Journal:  Front Hum Neurosci       Date:  2018-01-04       Impact factor: 3.169

Review 4.  Contribution of the GABAergic System to Non-Motor Manifestations in Premotor and Early Stages of Parkinson's Disease.

Authors:  Ane Murueta-Goyena; Ane Andikoetxea; Juan Carlos Gómez-Esteban; Iñigo Gabilondo
Journal:  Front Pharmacol       Date:  2019-10-30       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.